Recent News

By Category: Countermeasures

Standards for biothreat agent collection updated

A team of state, federal and local agencies, the National Institute of Standards and Technology, and various other organizations have combined forces to update the existing standard for sample collection and overall guidance when dealing with biothreat agents. Since 2001, there have been over 30,000 responses by U.S. law enforcement agencies to suspicious powders and  Read More »

New Sensor Could Detect Quickly Viral Bioterror Agents

Scientists at Boston University have developed a biological sensor that could be used to rapidly detect a wide range of viral pathogens including the lethal Ebola and Marburg viruses, the institution announced last week. As with other viruses that produce symptoms not necessarily indicative of viral infection, Marburg and Ebola outbreaks can be challenging to  Read More »

Soligenix Announces Issuance Of United States Patent For RiVax™, Its Vaccine Against Ricin Toxin

Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company, announced today that the United States Patent and Trademark Office (USPTO) has granted patent #7,829,668, entitled “Compositions and methods for modifying toxic effects of proteinaceous compounds…

Northrop Grumman testing autonomous biodetection instruments for BioWatch

DHS has awarded Northrop Grumman a contract to begin field testing a new generation of autonomous biodetection instruments as part of the BioWatch Gen-3 program.; the total potential value of the contract is $37 million over three years

MS drug to lead fight against bioterrorism

A drug already approved for treating multiple sclerosis show promise as a long sought treatment for victims of bioterrorist attack with botulinum neurotoxin — which is 10,000 times deadlier than cyanide and the most poisonous substance known to man